GET THE APP

Epidemiology and risk factor for hyperlipidemia in Pakistan | 56110
Journal of Clinical Trials

Journal of Clinical Trials
Open Access

ISSN: 2167-0870

+44 1478 350008

Epidemiology and risk factor for hyperlipidemia in Pakistan


4th International Conference on Clinical Trials

September 11-13, 2017 San Antonio, USA

Muhammad Akram, Muhammad Daniyal and Urooj Fatima

GC University, Pakistan
Hamdard University, Pakistan

Posters & Accepted Abstracts: J Clin Trials

Abstract :

Hyperlipidemia is very big health issue worldwide. Prevalence of hyperlipidemia is increasing in developed as well as developing countries. Hyperlipidemia incidence and prevalence is increasing in Pakistan due to change in the lifestyle of the Pakistani people. Hyperlipidemia is a major risk factor for cardiovascular disorders. Cardiovascular disorders are the leading cause of death in Pakistan. Hyperlipidemia has high mortality and morbidly because it is the major risk factor for developing stroke and cardiovascular disorders. Hyperlipidemia is very common in upper class society due to resting lifestyle and lack of exercise. This study aims to provide awareness about hyperlipidemia as well as an updated knowledge about the epidemiology and risk factor of hyperlipidemia in Pakistan.

Top